Gilead Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About GILD
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.
CEODaniel P. O'Day
CEODaniel P. O'Day
Employees17,600
Employees17,600
HeadquartersFoster City, California
HeadquartersFoster City, California
Founded1987
Founded1987
Employees17,600
Employees17,600
GILD Key Statistics
Market cap126.45B
Market cap126.45B
Price-Earnings ratio21.10
Price-Earnings ratio21.10
Dividend yield3.09%
Dividend yield3.09%
Average volume9.93M
Average volume9.93M
High today$102.02
High today$102.02
Low today$100.23
Low today$100.23
Open price$100.66
Open price$100.66
Volume2.29M
Volume2.29M
52 Week high$119.96
52 Week high$119.96
52 Week low$62.07
52 Week low$62.07
GILD News
Simply Wall St 1d
Statutory Profit Doesn't Reflect How Good Gilead Sciences' Earnings AreEven though Gilead Sciences, Inc.'s ( ) recent earnings release was robust, the market didn't seem to notice. Our analysis suggests that investors might be miss...
Analyst ratings
61%
of 31 ratingsBuy
61.3%
Hold
38.7%
Sell
0%
People also own
Based on the portfolios of people who own GILD. This list is generated using Robinhood data, and it’s not a recommendation.